IC Potash announces pending move of trading venue to Canadian Securities Exchange
November 07 2017 - 07:00AM
IC Potash Corp. (TSX:ICP) (OTCQB:ICPTF) (“IC
Potash” or the “Company”) is pleased to announce that the Board of
Directors of the Company has determined it is in the best interests
of shareholders to transfer the Company’s listing to The Canadian
Securities Exchange (the “CSE”). The CSE is operated by CNSX
Markets Inc. The CSE began operations in 2003 to provide a modern
and efficient trading and listing platform for companies accessing
Canadian public capital markets. Multiple companies in the medical
cannabis space are listed on the Canadian Stock Exchange.
The Company is working with the Canadian
regulators to voluntarily delist its issued and outstanding common
shares from the Toronto Stock Exchange (the “TSX”) in order that
the transfer to the CSE can be completed. The Company has now
received conditional approval to list its common shares on the CSE
and intends to make a seamless transition to the CSE on or about
November 22, 2017.
Mr. Mehdi Azodi, President and CEO stated, “Due
to the expansion of operation in the legal medical cannabis sector,
the CSE listing becomes an extremely attractive market for the
trading securities of IC Potash.”
About IC PotashIC Potash is establishing a
diversified portfolio of investments and interests with initial
focus on organic fertilizers and resource assets. ICP Organics’, a
wholly owned subsidiary of IC Potash Corp., focal point is
research, development and investment in the fertilizer and medical
cannabis sectors, with emphasis on organic fertilizers,
pesticide-free products, and specialty cannabis-related consumer
product branding and retail sales. Organic products provide
value-enhancing opportunities to medical cannabis and other
agricultural growers allowing the producers to sell products at
premium prices. The introduction of blockchain technology to the
cannabis industry will form the foundation for secure operational
processes and streamline domestic and international distribution
networks.
IC Potash intends to establish joint research
and development partnerships with Canadian Licensed Producers
operating under ACMPR regulations in Canada. The Company is also
establishing commercial relationships with medical and recreational
cannabis producers in the United States. IC Potash has made an
equity investment in cannabis operations in South America. As IC
Potash grows, it plans to build a diversified portfolio in
commercial-scale cannabis cultivators and related downstream
cannabis industry providers. The Company may invest in various
private and public companies in diversified sectors on an
opportunistic basis.
For more information, please visit
www.icpotash.com.
Forward-Looking Statements
Certain information set forth in this news
release may contain forward-looking statements that involve
substantial known and unknown risks and uncertainties and other
factors which may cause the actual results, performance or
achievements of IC Potash to be materially different from any
future results, performance or achievements expressed or implied by
such forward-looking statements. Forward-looking statements include
statements that use forward-looking terminology such as “may”,
“will”, “expect”, “anticipate”, “believe”, “continue”, “potential”
or the negative thereof or other variations thereof or comparable
terminology. Such forward-looking statements include, without
limitation, statements regarding planned investment activities
& related returns, trends in the markets for fertilizers and
medicinal or recreational use of cannabis, the timing or assurance
of the legalization of recreational cannabis, the timing for
completion of research and development activities, the potential
value of royalties from water and other resources, and other
statements that are not historical facts. These forward-looking
statements are subject to numerous risks and uncertainties, certain
of which are beyond the control of IC Potash, including, but not
limited to, changes in market trends, the completion, results and
timing of research undertaken by IC Potash, risks associated with
resource assets, the impact of general economic conditions,
commodity prices, industry conditions, dependence upon regulatory,
environmental, and governmental approvals, the uncertainty of
obtaining additional financing, and risks associated with cannabis
use for medicinal or recreational purposes. Readers are cautioned
that the assumptions used in the preparation of such information,
although considered reasonable at the time of preparation, may
prove to be imprecise and, as such, undue reliance should not be
placed on forward-looking statements.
For More Information, Please
Contact:
Mehdi Azodi, IC Potash, President & CEO, 416
779 3268, mazodi@icpotash.org